Jillian Martinez

Jillian Martinez serves as a key procurement professional within the CDC Office of Acquisition Services, supporting the agency’s mission to safeguard public health through strategic acquisition of critical scientific and technical capabilities. She manages a diverse portfolio of contracts focused on laboratory diagnostics, biomedical research tools, and data infrastructure essential for disease surveillance and rapid public health response. Her work centers on ensuring timely access to high-performance analytical instruments, clinical software systems, and specialized technical services that enable CDC’s operational readiness and scientific innovation across national and global health threats. Martinez maintains established relationships with leading contractors including General Dynamics Information Technology, Inc., Cepheid, GlaxoSmithKline, LLC, New York City Health & Hospitals Corp, and MRIGLOBAL. These partnerships reflect a balanced approach to sourcing advanced diagnostic platforms, biosafety-compliant equipment, epidemiological data systems, and contract research services from both large prime contractors and specialized technical providers. Her procurement strategy prioritizes reliability, regulatory compliance, and scalability to meet the dynamic demands of public health emergencies and long-term research initiatives. Her contracting patterns show a strong preference for open competition, with 87.5% of acquisitions conducted without set-aside restrictions, reflecting the technical complexity and scale of CDC’s requirements. However, she consistently allocates 12.5% of awards to Total Small Business Set-Asides under FAR 19.5, demonstrating a deliberate commitment to fostering innovation and capacity within the small business community without compromising mission-critical performance standards. Martinez’s primary NAICS focus areas include Analytical Laboratory Instrument Manufacturing (334516), Software Publishing (513210), and Professional, Scientific, and Technical Services (541990 and 541690). She routinely procures next-generation PCR systems, real-time data analytics platforms, laboratory information management systems, and specialized consulting services in epidemiology and biocontainment, underscoring her deep expertise in supporting the technical infrastructure of modern public health science.